Flex Foods Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: July 26, 2025, 2:35 pm

Competitors of Flex Foods Ltd

All Competitor Stocks of Flex Foods Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:03 am

Below is a detailed analysis of the quarterly data for Flex Foods Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 45.51 Cr.. The value appears strong and on an upward trend. It has increased from 28.10 Cr. (Dec 2024) to 45.51 Cr., marking an increase of 17.41 Cr..
• For Expenses, as of Mar 2025, the value is 42.28 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.51 Cr. (Dec 2024) to 42.28 Cr., marking an increase of 13.77 Cr..
• For Operating Profit, as of Mar 2025, the value is 3.23 Cr.. The value appears strong and on an upward trend. It has increased from -0.41 Cr. (Dec 2024) to 3.23 Cr., marking an increase of 3.64 Cr..
• For OPM %, as of Mar 2025, the value is 7.10%. The value appears strong and on an upward trend. It has increased from -1.46% (Dec 2024) to 7.10%, marking an increase of 8.56%.
• For Other Income, as of Mar 2025, the value is 0.22 Cr.. The value appears strong and on an upward trend. It has increased from 0.05 Cr. (Dec 2024) to 0.22 Cr., marking an increase of 0.17 Cr..
• For Interest, as of Mar 2025, the value is 5.84 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.71 Cr. (Dec 2024) to 5.84 Cr., marking an increase of 0.13 Cr..
• For Depreciation, as of Mar 2025, the value is 4.13 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.19 Cr. (Dec 2024) to 4.13 Cr., marking a decrease of 0.06 Cr..
• For Profit before tax, as of Mar 2025, the value is -6.52 Cr.. The value appears strong and on an upward trend. It has increased from -10.26 Cr. (Dec 2024) to -6.52 Cr., marking an increase of 3.74 Cr..
• For Tax %, as of Mar 2025, the value is -19.63%. The value appears to be increasing, which may not be favorable. It has increased from -25.34% (Dec 2024) to -19.63%, marking an increase of 5.71%.
• For Net Profit, as of Mar 2025, the value is -5.24 Cr.. The value appears strong and on an upward trend. It has increased from -7.66 Cr. (Dec 2024) to -5.24 Cr., marking an increase of 2.42 Cr..
• For EPS in Rs, as of Mar 2025, the value is -4.21. The value appears strong and on an upward trend. It has increased from -6.15 (Dec 2024) to -4.21, marking an increase of 1.94.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:27 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:18 pm

Below is a detailed analysis of the balance sheet data for Flex Foods Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
• For Reserves, as of Mar 2025, the value is 29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 63.00 Cr. (Mar 2024) to 29.00 Cr., marking a decrease of 34.00 Cr..
• For Borrowings, as of Mar 2025, the value is 280.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 263.00 Cr. (Mar 2024) to 280.00 Cr., marking an increase of 17.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 66.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 55.00 Cr. (Mar 2024) to 66.00 Cr., marking an increase of 11.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 388.00 Cr.. The value appears to be improving (decreasing). It has decreased from 392.00 Cr. (Mar 2024) to 388.00 Cr., marking a decrease of 4.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 260.00 Cr.. The value appears to be declining and may need further review. It has decreased from 268.00 Cr. (Mar 2024) to 260.00 Cr., marking a decrease of 8.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 2.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 129.00 Cr.. The value appears strong and on an upward trend. It has increased from 122.00 Cr. (Mar 2024) to 129.00 Cr., marking an increase of 7.00 Cr..
• For Total Assets, as of Mar 2025, the value is 388.00 Cr.. The value appears to be declining and may need further review. It has decreased from 392.00 Cr. (Mar 2024) to 388.00 Cr., marking a decrease of 4.00 Cr..

However, the Borrowings (280.00 Cr.) are higher than the Reserves (29.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Key Financial Ratios

After reviewing the key financial ratios for Flex Foods Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -26.10. This value is below the healthy minimum of 5. It has decreased from -20.83 (Mar 24) to -26.10, marking a decrease of 5.27.
• For Diluted EPS (Rs.), as of Mar 25, the value is -26.10. This value is below the healthy minimum of 5. It has decreased from -20.83 (Mar 24) to -26.10, marking a decrease of 5.27.
• For Cash EPS (Rs.), as of Mar 25, the value is -12.72. This value is below the healthy minimum of 3. It has decreased from -7.79 (Mar 24) to -12.72, marking a decrease of 4.93.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 33.57. It has decreased from 60.44 (Mar 24) to 33.57, marking a decrease of 26.87.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 33.57. It has decreased from 60.44 (Mar 24) to 33.57, marking a decrease of 26.87.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 120.49. It has increased from 97.41 (Mar 24) to 120.49, marking an increase of 23.08.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -3.00. This value is below the healthy minimum of 2. It has decreased from -1.43 (Mar 24) to -3.00, marking a decrease of 1.57.
• For PBIT / Share (Rs.), as of Mar 25, the value is -16.39. This value is below the healthy minimum of 0. It has decreased from -14.46 (Mar 24) to -16.39, marking a decrease of 1.93.
• For PBT / Share (Rs.), as of Mar 25, the value is -34.70. This value is below the healthy minimum of 0. It has decreased from -28.30 (Mar 24) to -34.70, marking a decrease of 6.40.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -26.10. This value is below the healthy minimum of 2. It has decreased from -20.83 (Mar 24) to -26.10, marking a decrease of 5.27.
• For PBDIT Margin (%), as of Mar 25, the value is -2.49. This value is below the healthy minimum of 10. It has decreased from -1.46 (Mar 24) to -2.49, marking a decrease of 1.03.
• For PBIT Margin (%), as of Mar 25, the value is -13.59. This value is below the healthy minimum of 10. It has increased from -14.84 (Mar 24) to -13.59, marking an increase of 1.25.
• For PBT Margin (%), as of Mar 25, the value is -28.79. This value is below the healthy minimum of 10. It has increased from -29.05 (Mar 24) to -28.79, marking an increase of 0.26.
• For Net Profit Margin (%), as of Mar 25, the value is -21.66. This value is below the healthy minimum of 5. It has decreased from -21.38 (Mar 24) to -21.66, marking a decrease of 0.28.
• For Return on Networth / Equity (%), as of Mar 25, the value is -77.75. This value is below the healthy minimum of 15. It has decreased from -34.45 (Mar 24) to -77.75, marking a decrease of 43.30.
• For Return on Capital Employeed (%), as of Mar 25, the value is -8.19. This value is below the healthy minimum of 10. It has decreased from -6.51 (Mar 24) to -8.19, marking a decrease of 1.68.
• For Return On Assets (%), as of Mar 25, the value is -8.36. This value is below the healthy minimum of 5. It has decreased from -6.60 (Mar 24) to -8.36, marking a decrease of 1.76.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 4.86. This value exceeds the healthy maximum of 1. It has increased from 2.61 (Mar 24) to 4.86, marking an increase of 2.25.
• For Total Debt / Equity (X), as of Mar 25, the value is 6.68. This value exceeds the healthy maximum of 1. It has increased from 3.47 (Mar 24) to 6.68, marking an increase of 3.21.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.38. It has increased from 0.31 (Mar 24) to 0.38, marking an increase of 0.07.
• For Current Ratio (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1.5. It has decreased from 0.96 (Mar 24) to 0.76, marking a decrease of 0.20.
• For Quick Ratio (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.55 (Mar 24) to 0.44, marking a decrease of 0.11.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.99. This value is below the healthy minimum of 4. It has increased from 0.86 (Mar 24) to 0.99, marking an increase of 0.13.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -2.40 (Mar 24) to 0.00, marking an increase of 2.40.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -6.41 (Mar 24) to 0.00, marking an increase of 6.41.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 102.40 (Mar 24) to 0.00, marking a decrease of 102.40.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 106.41 (Mar 24) to 0.00, marking a decrease of 106.41.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -0.16. This value is below the healthy minimum of 3. It has decreased from -0.10 (Mar 24) to -0.16, marking a decrease of 0.06.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.42. This value is below the healthy minimum of 3. It has increased from -0.50 (Mar 24) to -0.42, marking an increase of 0.08.
• For Enterprise Value (Cr.), as of Mar 25, the value is 329.74. It has decreased from 396.34 (Mar 24) to 329.74, marking a decrease of 66.60.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.20. This value is within the healthy range. It has decreased from 3.27 (Mar 24) to 2.20, marking a decrease of 1.07.
• For EV / EBITDA (X), as of Mar 25, the value is -88.17. This value is below the healthy minimum of 5. It has increased from -222.98 (Mar 24) to -88.17, marking an increase of 134.81.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has decreased from 1.13 (Mar 24) to 0.34, marking a decrease of 0.79.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 102.40 (Mar 24) to 0.00, marking a decrease of 102.40.
• For Price / BV (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has decreased from 1.82 (Mar 24) to 1.25, marking a decrease of 0.57.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.34. This value is below the healthy minimum of 1. It has decreased from 1.13 (Mar 24) to 0.34, marking a decrease of 0.79.
• For EarningsYield, as of Mar 25, the value is -0.62. This value is below the healthy minimum of 5. It has decreased from -0.18 (Mar 24) to -0.62, marking a decrease of 0.44.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness